References
1. CDC. Atrial Fibrillation
Fact Sheet. Published 2020.
http://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_atrial_fibrillation.htm
2. Verma A, Champagne J, Sapp
J, et al. Discerning the incidence of symptomatic and asymptomatic
episodes of atrial fibrillation before and after catheter ablation
(DISCERN AF): a prospective, multicenter study. JAMA Intern Med.
2013;173(2):149-156.
3. Heidt ST, Kratz A,
Najarian K, et al. Symptoms In Atrial Fibrillation: A Contemporary
Review And Future Directions. J Atr Fibrillation.
2016;9(1):1422.
4. Julian Chun KR, Perrotta
L, Bordignon S, et al. Complications in Catheter Ablation of Atrial
Fibrillation in 3,000 Consecutive Procedures. JACC: Clinical
Electrophysiology. 2017;3(2):154-161.
5. Corrado D, Zorzi A. Risk
of Catheter Ablation for Atrial Fibrillation. JACC Clin
Electrophysiol. 2017;3(12):1434-1436.
6. January Craig T., Wann L.
Samuel, Calkins Hugh, et al. 2019 AHA/ACC/HRS Focused Update of the 2014
AHA/ACC/HRS Guideline for the Management of Patients With Atrial
Fibrillation: A Report of the American College of Cardiology/American
Heart Association Task Force on Clinical Practice Guidelines and the
Heart Rhythm Society in Collaboration With the Society of Thoracic
Surgeons. Circulation. 2019;140(2):e125-e151.
7. Packer DL, Mark DB, Robb
RA, et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on
Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With
Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA.
Published online March 15, 2019.
doi:10.1001/jama.2019.0693
8. Schnabel RB, Pecen L,
Rzayeva N, et al. Symptom Burden of Atrial Fibrillation and Its Relation
to Interventions and Outcome in Europe. J Am Heart Assoc.
2018;7(11).
doi:10.1161/jaha.117.007559
9. Mark DB, Anstrom KJ, Sheng
S, et al. Effect of Catheter Ablation vs Medical Therapy on Quality of
Life Among Patients With Atrial Fibrillation: The CABANA Randomized
Clinical Trial. JAMA. Published online 2019.
doi:10.1001/jama.2019.0692
10. Reynolds MR, Walczak J,
White SA, Cohen DJ, Wilber DJ. Improvements in symptoms and quality of
life in patients with paroxysmal atrial fibrillation treated with
radiofrequency catheter ablation versus antiarrhythmic drugs. Circ
Cardiovasc Qual Outcomes. 2010;3(6):615-623.
11. Sultan A, Lüker J,
Andresen D, et al. Predictors of Atrial Fibrillation Recurrence after
Catheter Ablation: Data from the German Ablation Registry. Sci
Rep. 2017;7(1):16678.
12. Stacey D, Légaré F, Lewis
K, et al. Decision aids for people facing health treatment or screening
decisions. Cochrane Database Syst Rev. 2017;4:CD001431.
13. Seaburg L, Hess EP,
Coylewright M, Ting HH, McLeod CJ, Montori VM. Shared decision making in
atrial fibrillation: where we are and where we should be going.Circulation. 2014;129(6):704-710.
14. Coylewright M, Holmes DR
Jr. Caution Regarding Government-Mandated Shared Decision Making for
Patients With Atrial Fibrillation. Circulation.
2017;135(23):2211-2213.
15. Zeballos-Palacios CL,
Hargraves IG, Noseworthy PA, et al. Developing a Conversation Aid to
Support Shared Decision Making: Reflections on Designing Anticoagulation
Choice. Mayo Clin Proc. 2019;94(4):686-696.
16. Thomson R, Robinson A,
Greenaway J, Lowe P, DARTS Team. Development and description of a
decision analysis based decision support tool for stroke prevention in
atrial fibrillation. Qual Saf Health Care. 2002;11(1):25-31.
17. Man-Son-Hing M, Gage BF,
Montgomery AA, et al. Preference-based antithrombotic therapy in atrial
fibrillation: implications for clinical decision making. Med Decis
Making. 2005;25(5):548-559.
18. Noseworthy PA, Brito JP,
Kunneman M, et al. Shared decision-making in atrial fibrillation:
navigating complex issues in partnership with the patient. J
Interv Card Electrophysiol. Published online October 17, 2018.
doi:10.1007/s10840-018-0465-5
19. Ali-Ahmed F, Pieper K,
North R, et al. Shared decision-making in atrial fibrillation:
patient-reported involvement in treatment decisions. Eur Heart J
Qual Care Clin Outcomes. 2020;6(4):263-272.
20. Joseph-Williams N, Elwyn
G, Edwards A. Knowledge is not power for patients: a systematic review
and thematic synthesis of patient-reported barriers and facilitators to
shared decision making. Patient Educ Couns. 2014;94(3):291-309.
21. Clifford AM, Ryan J,
Walsh C, McCurtin A. What information is used in treatment decision
aids? A systematic review of the types of evidence populating health
decision aids. BMC Med Inform Decis Mak. 2017;17(1):22.
22. Elwyn G, O’Connor A,
Stacey D, et al. Developing a quality criteria framework for patient
decision aids: online international Delphi consensus process.BMJ. 2006;333(7565):417.
23. Sepucha KR, Scholl I.
Measuring Shared Decision Making. Circ Cardiovasc Qual Outcomes.
Published online 2014.
doi:10.1161/CIRCOUTCOMES.113.000350
24. Chew LD, Bradley KA,
Boyko EJ. Brief questions to identify patients with inadequate health
literacy. Fam Med. 2004;36(8):588-594.
25. McNaughton CD, Cavanaugh
KL, Kripalani S, Rothman RL, Wallston KA. Validation of a Short, 3-Item
Version of the Subjective Numeracy Scale. Med Decis Making.
2015;35(8):932-936.
26. Dorian P, Guerra PG, Kerr
CR, et al. Validation of a new simple scale to measure symptoms in
atrial fibrillation: the Canadian Cardiovascular Society Severity in
Atrial Fibrillation scale. Circ Arrhythm Electrophysiol.
2009;2(3):218-224.
27. Degner LF, Sloan JA,
Venkatesh P. The Control Preferences Scale. Can J Nurs Res.
1997;29(3):21-43.
28. O’Connor AM. Validation
of a decisional conflict scale. Med Decis Making.
1995;15(1):25-30.
29. Brehaut JC, O’Connor AM,
Wood TJ, et al. Validation of a decision regret scale. Med Decis
Making. 2003;23(4):281-292.
30. Hsieh HF, Shannon SE.
Three approaches to qualitative content analysis. Qual Health
Res. 2005;15(9):1277-1288.
31. Feldman-Stewart D,
O’Brien MA, Clayman ML, et al. Providing information about options in
patient decision aids. BMC Med Inform Decis Mak. 2013;13 Suppl
2:S4.
32. Vaisson G, Provencher T,
Dugas M, et al. User Involvement in the Design and Development of
Patient Decision Aids and Other Personal Health Tools: A Systematic
Review. Med Decis Making. 2021;41(3):261-274.
33. Volk RJ, Llewellyn-Thomas
H. 2012 Update of the IPDAS Collaboration Background Document. Published
2012. Accessed July 15, 2021. http://ipdas.ohri.ca/resources.html
34. Khalil V, Blackley S,
Subramaniam A. Evaluation of a pharmacist-led shared decision-making in
atrial fibrillation and patients’ satisfaction-a before and after pilot
study. Ir J Med Sci. 2021;190(2):819-824.
35. Kunneman M, Branda ME,
Hargraves IG, et al. Assessment of Shared Decision-making for Stroke
Prevention in Patients With Atrial Fibrillation: A Randomized Clinical
Trial. JAMA Intern Med. 2020;180(9):1215-1224.
36. Eckman MH, Costea A,
Attari M, et al. Shared decision-making tool for thromboprophylaxis in
atrial fibrillation - A feasibility study. Am Heart J.
2018;199:13-21.
37. Kapoor A, Andrade A,
Hayes A, et al. Usability, Perceived Usefulness, and Shared
Decision-Making Features of the AFib 2gether Mobile App: Protocol for a
Single-Arm Intervention Study. JMIR Res Protoc.
2021;10(2):e21986.